Overview

Update
Status
Acquired by on May 29, 2013
IPO / Stock
Went Public on Apr 11, 2013 / NASDAQ:OMTH
Headquarters:
Princeton, NJ
Description:
Omthera Pharmaceuticals develops therapies for patients with elevated triglyceride levels and increased risk of cardiovascular disease.
Founders:
, ,
Categories:
Health Care, Biotechnology, Medical
Website:
http://www.omthera.com

Company Details

Update
Founded:
2008
Contact:
908-741-4399
Employees:
11 - 50 | 3 in Crunchbase

Omthera Pharmaceuticals, Inc. is an emerging specialty pharmaceuticals company focusing its efforts on the clinical development of new therapies for dyslipidemia. Led by a team of experts with exceptional experience in developing new therapies for lipid disorders, Omthera is dedicated to developing innovative therapies for the millions of patients who have elevated triglyceride levels and increased risk of cardiovascular disease.

Funding Rounds (4) - $60.16M

Update
DateAmount / RoundValuationLead InvestorInvestors
Feb, 2013$17.6M / Debt Financing0
Mar, 2011$33.9M / Series B2
Mar, 2010$6.5M / Series A1
Nov, 2009$2.16M / Venture0

Current Team (3)

Update

Board Members and Advisors (3)

Update

Offices/Locations (1)

Update
  • Headquarters

    707 State Road

    Princeton, NJ 08540

    USA

Past Team (3)

Update

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos